The Polycomb group protein EZH2 directly controls DNA methylation
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
The establishment and maintenance of epigenetic gene silencing is fundamental to cell determination and function. The essential epigenetic systems involved in heritable repression of gene activity are the Polycomb group (PcG) proteins and the DNA methylation systems. Here we show that the corresponding silencing pathways are mechanistically linked. We find that the PcG protein EZH2 (Enhancer of Zeste homolog 2) interacts-within the context of the Polycomb repressive complexes 2 and 3 (PRC2/3)-with DNA methyltransferases (DNMTs) and associates with DNMT activity in vivo. Chromatin immunoprecipitations indicate that binding of DNMTs to several EZH2-repressed genes depends on the presence of EZH2. Furthermore, we show by bisulphite genomic sequencing that EZH2 is required for DNA methylation of EZH2-target promoters. Our results suggest that EZH2 serves as a recruitment platform for DNA methyltransferases, thus highlighting a previously unrecognized direct connection between two key epigenetic repression systems.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Neither did Dnmt3a, another chromatin modifying enzyme that is a PRC2 component and is frequently genetically inactivated in myeloid neoplasms (Fig. 5) (31”
From Runx1 regulation of Pu.1 corepressor/coactivator exchange identifies specific molecular targets for leukemia differentiation therapy (2014) · cites this paper as [32]
Citations
Cites
DNA methylation patterns and epigenetic memory
Bird, A. (2002) · Genes & Development · doi:10.1101/gad.947102 · Cited by 7,124
Jaenisch, R., & Bird, A. (2003) · Nature Genetics · doi:10.1038/ng1089 · Cited by 6,325
Role of Histone H3 Lysine 27 Methylation in Polycomb-Group Silencing
Cao, R., Wang, L., Wang, H., Xia, L., Erdjument-Bromage, H., Tempst, P., Jones, R. S., & Zhang, Y. (2002) · Science · doi:10.1126/science.1076997 · Cited by 3,775
Epigenetics in human disease and prospects for epigenetic therapy
Egger, G., Liang, G., Aparicio, A., & Jones, P. A. (2004) · Nature · doi:10.1038/nature02625 · Cited by 3,232
Kuzmichev, A., Nishioka, K., Erdjument-Bromage, H., Tempst, P., & Reinberg, D. (2002) · Genes & Development · doi:10.1101/gad.1035902 · Cited by 1,596
Histone Methyltransferase Activity of a Drosophila Polycomb Group Repressor Complex
Müller, J., Hart, C. M., Francis, N. J., Vargas, M. L., Sengupta, A., Wild, B., Miller, E. L., O'Connor, M. B., Kingston, R. E., & Simon, J. A. (2002) · Cell · doi:10.1016/s0092-8674(02)00976-5 · Cited by 1,562
Czermin, B., Melfi, R., McCabe, D., Seitz, V., Imhof, A., & Pirrotta, V. (2002) · Cell · doi:10.1016/s0092-8674(02)00975-3 · Cited by 1,533
Control of CpNpG DNA methylation by the KRYPTONITE histone H3 methyltransferase
Jackson, J. P., Lindroth, A. M., Cao, X., & Jacobsen, S. E. (2002) · Nature · doi:10.1038/nature731 · Cited by 1,251
Lehnertz, B., Ueda, Y., Derijck, A. A. H. A., Braunschweig, U., Perez-Burgos, L., Kubicek, S., Chen, T., Li, E., Jenuwein, T., & Peters, A. H. F. M. (2003) · Current Biology · doi:10.1016/s0960-9822(03)00432-9 · Cited by 1,245
Role of Histone H3 Lysine 27 Methylation in X Inactivation
Plath, K., Fang, J., Mlynarczyk-Evans, S. K., Cao, R., Worringer, K. A., Wang, H., de la Cruz, C. C., Otte, A. P., Panning, B., & Zhang, Y. (2003) · Science · doi:10.1126/science.1084274 · Cited by 1,195
Cited by
Items 901–1,000 of 1,004
Non-BRAF Mutant Melanoma: Molecular Features and Therapeutical Implications
Vanni, I., Tanda, E. T., Dalmasso, B., Pastorino, L., Andreotti, V., Bruno, W., Boutros, A., Spagnolo, F., & Ghiorzo, P. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.00172 · Cited by 47
Reversing Post-Infectious Epigenetic-Mediated Immune Suppression
Abhimanyu, A., Ontiveros, C. O., Guerra-Resendez, R. S., Nishiguchi, T., Ladki, M., Hilton, I. B., Schlesinger, L. S., & DiNardo, A. R. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.688132 · Cited by 47
Wang, B., Liu, Y., Luo, F., Xu, Y., Qin, Y., Lü, X., Xu, W., Shi, L., Liu, Q., & Xiang, Q. (2014) · Archives of Toxicology · doi:10.1007/s00204-014-1435-z · Cited by 47
Regulation of Stem Cell Differentiation by Histone Methyltransferases and Demethylases
Pasini, D., Bracken, A. P., Agger, K., Christensen, J. F., Hansen, K. H., Cloos, P. A., & Helin, K. (2008) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2008.73.009 · Cited by 47
Changchien, Y.-C., Tátrai, P., Papp, G., Sápi, J., Fónyad, L., Szendrői, M., Pápai, Z., & Sápi, Z. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-216 · Cited by 47
Mozhui, K., & Pandey, A. K. (2017) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2017.02.006 · Cited by 46
Polycomb genes, miRNA, and their deregulation in B-cell malignancies
Wang, G. G., Konze, K. D., & Tao, J. (2015) · Blood · doi:10.1182/blood-2014-10-606822 · Cited by 46
Global identification of genes targeted by DNMT3b for epigenetic silencing in lung cancer
Teneng, I., Tellez, C. S., Picchi, M. A., Klinge, D. M., Yingling, C. M., Snider, A. M., Liu, Y., & Belinsky, S. A. (2014) · Oncogene · doi:10.1038/onc.2013.580 · Cited by 47
Polycomb Binding Precedes Early-Life Stress Responsive DNA Methylation at the Avp Enhancer
Murgatroyd, C., & Spengler, D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090277 · Cited by 44
Nakahara, O., Takamori, H., Iwatsuki, M., Baba, Y., Sakamoto, Y., Tanaka, H., Chikamoto, A., Horino, K., Beppu, T., Kanemitsu, K., et al. (2011) · Annals of Surgical Oncology · doi:10.1245/s10434-011-2068-6 · Cited by 46
Hypoxia-inducible factor (HIF) inhibitors: a patent survey (2011-2015)
Ban, H. S., Uto, Y., Won, M., & Nakamura, H. (2016) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2016.1146252 · Cited by 44
Lv, L., He, L., Chen, S., Yu, Y., Che, G., Tao, X., Wang, S., Jian, Z., & Zhang, X. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01383 · Cited by 46
Epigenetic stability of embryonic stem cells and developmental potential
Pannetier, M., & Feil, R. (2007) · Trends in biotechnology · doi:10.1016/j.tibtech.2007.09.003 · Cited by 46
Functional Genomics of the 9p21.3 Locus for Atherosclerosis: Clarity or Confusion?
Chen, H.-H., Almontashiri, N. A. M., Antoine, D., & Stewart, A. F. R. (2014) · Current Cardiology Reports · doi:10.1007/s11886-014-0502-7 · Cited by 45
Targeting of cancer stem cells by inhibitors of DNA and histone methylation
Momparler, R. L., & Côté, S. (2015) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2015.1051220 · Cited by 45
Zheng, Y., He, L., Wan, Y., & Song, J. (2013) · Stem Cells and Development · doi:10.1089/scd.2012.0172 · Cited by 43
Epigenetic regulation of bone cells
Park‐Min, K. H. (2016) · Connective Tissue Research · doi:10.1080/03008207.2016.1177037 · Cited by 45
Genomics and Therapeutic Vulnerabilities of Primary Bone Tumors
Scotlandi, K., Hattinger, C. M., Pellegrini, E., Gambarotti, M., & Serra, M. (2020) · Cells · doi:10.3390/cells9040968 · Cited by 45
Epigenetics and Plant Breeding
Tsaftaris, A. S., Polidoros, A. N., Kapazoglou, A., Tani, E., & Kovacevic, N. M. (2007) · Wiley eBooks · doi:10.1002/9780470380130.ch2 · Cited by 45
DNA methyltransferase 3b preferentially associates with condensed chromatin
Kashiwagi, K., Nimura, K., Ura, K., & Kaneda, Y. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq870 · Cited by 45
Walker, C. L. (2011) · Birth Defects Research Part A Clinical and Molecular Teratology · doi:10.1002/bdra.20827 · Cited by 45
Regulation and function of mammalian DNA methylation patterns: a genomic perspective
Wu, H., Tao, J., & Sun, Y. E. (2012) · Briefings in Functional Genomics · doi:10.1093/bfgp/els011 · Cited by 45
The roles of cross-talk epigenetic patterns inArabidopsis thaliana
Wang, J., Meng, X., Yuan, C., Harrison, A., & Chen, M. (2015) · Briefings in Functional Genomics · doi:10.1093/bfgp/elv025 · Cited by 45
Mechanisms of epigenetic deregulation in lymphoid neoplasms
Jiang, Y., Hatzi, K., & Shaknovich, R. (2013) · Blood · doi:10.1182/blood-2012-12-451799 · Cited by 46
Epigenetic Architecture and miRNA: Reciprocal Regulators
Wiklund, E. D., Kjems, J., & Clark, S. J. (2010) · Epigenomics · doi:10.2217/epi.10.51 · Cited by 44
Combining Genomic and Proteomic Approaches for Epigenetics Research
Han, Y., & Garcia, B. A. (2013) · Epigenomics · doi:10.2217/epi.13.37 · Cited by 45
Symmank, J., Bayer, C., Schmidt, C., Hahn, A., Pensold, D., & Zimmer‐Bensch, G. (2018) · Epigenetics · doi:10.1080/15592294.2018.1475980 · Cited by 44
Roels, J., Thénoz, M., Szarzyńska‐Zawadzka, B., Landfors, M., Coninck, S. D., Demoen, L., Provez, L., Kuchmiy, A. A., Strubbe, S., Reunes, L., et al. (2020) · Blood Cancer Discovery · doi:10.1158/2643-3230.bcd-20-0059 · Cited by 44
Molecular mechanisms of the microRNA-132 during tumor progressions
Moghbeli, M., Zangouei, A. S., Navaei, Z. N., & Taghehchian, N. (2021) · Cancer Cell International · doi:10.1186/s12935-021-02149-7 · Cited by 45
DNA Repair and the Control of DNA Methylation
Schär, P., & Fritsch, O. (2010) · Springer eBooks · doi:10.1007/978-3-7643-8989-5_3 · Cited by 44
Overexpression of MYC and EZH2 cooperates to epigenetically silence MST1 expression
Abali, G. K., Alptekin, A., & Cinar, B. (2014) · Epigenetics · doi:10.4161/epi.27957 · Cited by 44
Synergistic chromatin repression of the tumor suppressor geneRARBin human prostate cancers
Moison, C., Assemat, F., Daunay, A., Tost, J., Guieysse‐Peugeot, A., & Arimondo, P. B. (2014) · Epigenetics · doi:10.4161/epi.27869 · Cited by 44
Zhuang, C., Wang, P., Huang, D., Xu, L., Wang, X., Wang, L., & Hu, L. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3336 · Cited by 44
Gong, C., Yao, S. J., Gomes, A., Man, E. P. S., Lee, H., Gong, G., Chang, S., Kim, S.-B., Fujino, K., Kim, S.-W., et al. (2016) · Oncogenesis · doi:10.1038/oncsis.2016.23 · Cited by 44
Cai, H., Memarzadeh, S., Stoyanova, T. I., Beharry, Z. M., Kraft, A. S., & Witte, O. N. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0228 · Cited by 43
LSD1 collaborates with EZH2 to regulate expression of interferon-stimulated genes
Jin, Y., Huo, B., Fu, X., Tian, H., Zhang, Y., Guo, Y., & Hu, X. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.01.055 · Cited by 43
Parfett, C. L. J., & Desaulniers, D. M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18061179 · Cited by 44
Lu, X., He, X., Su, J., Wang, J., Liu, X., Xu, K., De, W., Zhang, E., Guo, R., & Shi, Y. E. (2018) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2018.05.016 · Cited by 43
Xia, J., Li, J., Tian, L., Ren, X., Liu, C., & Liang, C. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c00047 · Cited by 43
Patra, S. K., & Szyf, M. (2008) · FEBS Journal · doi:10.1111/j.1742-4658.2008.06658.x · Cited by 44
MeInfoText: associated gene methylation and cancer information from text mining
Fang, Y., Huang, H., & Juan, H. (2008) · BMC Bioinformatics · doi:10.1186/1471-2105-9-22 · Cited by 43
Senescence; an endogenous anticancer mechanism
Vargas, J. E., Feltes, B. C., Poloni, J. D. F., Lenz, G., & Bonatto, D. (2012) · Frontiers in bioscience · doi:10.2741/4074 · Cited by 43
Golding, M. C., Zhang, L., & Mann, M. R. W. (2010) · Cell stem cell · doi:10.1016/j.stem.2010.03.014 · Cited by 43
Tsubota, S., Kishida, S., Shimamura, T., Ohira, M., Yamashita, S., Cao, D., Kiyonari, S., Ushijima, T., & Kadomatsu, K. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-3144 · Cited by 43
Mottok, A., Jurinović, V., Farinha, P., Rosenwald, A., Leich, E., Ott, G., Horn, H., Klapper, W., Boesl, M. R., Hiddemann, W., et al. (2017) · Blood · doi:10.1182/blood-2017-08-799080 · Cited by 43
Gu, X., Hu, Z., Ebrahem, Q., Crabb, J. S., Mahfouz, R. Z., Radivoyevitch, T., Crabb, J. W., & Saunthararajah, Y. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.562447 · Cited by 42
Curcumin and cancer; are long non-coding RNAs missing link?
Shabgah, A. G., Zarifi, S. H., Kiapey, S. S. M., Ezzatifar, F., Pahlavani, N., Soleimani, D., Haftcheshmeh, S. M., Mohammadi, H., & Navashenaq, J. G. (2021) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2021.04.001 · Cited by 42
Ahmadieh-Yazdi, A., Mahdavinezhad, A., Tapak, L., Nouri, F., Taherkhani, A., & Afshar, S. (2023) · Scientific Reports · doi:10.1038/s41598-023-46633-8 · Cited by 42
Zhang, Q., Shi, Y., Liu, S., Yang, W., Chen, H., Guo, N., Sun, W., Zhao, Y., Ren, Y., Ren, Y., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.113714 · Cited by 42
Enhancer of zeste homolog 2: A potential target for tumor therapy
Xiao, Y. (2011) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2011.01.005 · Cited by 42
Application of DNA methyltransferases in targeted DNA methylation
Jeltsch, A., Jurkowska, R. Z., Jurkowski, T. P., Liebert, K., Rathert, P., & Schlickenrieder, M. (2007) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-007-0966-0 · Cited by 42
The emerging role of RNA in the regulation of gene transcription in human cells
Morris, K. V. (2011) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2011.02.017 · Cited by 42
Enroth, S., Rada-Iglesias, Á., Andersson, R., Wallerman, O., Wanders, A., Påhlman, L., Komorowski, J., & Wadelius, C. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-450 · Cited by 42
The role of epigenetic variation in the pathogenesis of systemic lupus erythematosus
Hughes, T. K., & Sawalha, A. H. (2011) · Arthritis Research & Therapy · doi:10.1186/ar3484 · Cited by 42
Mogamulizumab for the treatment of T-cell lymphoma
Makita, S., & Tobinai, K. (2017) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2017.1347634 · Cited by 42
Qiu, C., Li, S., Sun, D., & Yang, S. (2019) · Oncology Letters · doi:10.3892/ol.2019.11237 · Cited by 42
Chromatin regulation and dynamics in stem cells
Klein, D. C., & Hainer, S. J. (2019) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2019.11.002 · Cited by 43
Hapugaswatta, H., Amarasena, P., Premaratna, R., Seneviratne, K. N., & Jayathilaka, N. (2020) · Journal of Biomedical Science · doi:10.1186/s12929-020-0620-z · Cited by 42
Tazemetostat for Advanced Epithelioid Sarcoma: Current Status and Future Perspectives
Simeone, N., Frezza, A. M., Zaffaroni, N., & Stacchiotti, S. (2020) · Future Oncology · doi:10.2217/fon-2020-0781 · Cited by 42
Epigenetic regulation in Huntington's disease
Hyeon, J. W., Kim, A. H., & Yano, H. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.105074 · Cited by 42
Misregulation of the expression and activity of DNA methyltransferases in cancer
Mensah, I. K., Norvil, A. B., AlAbdi, L., McGovern, S. E., Petell, C. J., He, M., & Gowher, H. (2021) · NAR Cancer · doi:10.1093/narcan/zcab045 · Cited by 42
Downregulation of MEG3 and upregulation of EZH2 cooperatively promote neuroblastoma progression
Ye, M., Gao, R., Chen, S., Wei, M., Wang, J., Zhang, B., Wu, S., Xu, Y., Wu, P., Chen, X., et al. (2022) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17258 · Cited by 42
EZH2: An Accomplice of Gastric Cancer
Yu, W., Liu, N., Song, X., Chen, L., Wang, M., Xiao, G., Li, T., Wang, Z., & Zhang, Y. (2023) · Cancers · doi:10.3390/cancers15020425 · Cited by 42
The function of the epigenome in cell reprogramming
Lanzuolo, C., & Orlando, V. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-6420-8 · Cited by 42
Histone H2A.Z deregulation in prostate cancer. Cause or effect?
Dryhurst, D. D., & Ausió, J. (2014) · Cancer and Metastasis Reviews · doi:10.1007/s10555-013-9486-9 · Cited by 42
Kumari, D., & Usdin, K. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu378 · Cited by 42
Epigenome remodelling in breast cancer: insights from an early in vitro model of carcinogenesis
Locke, W. J., & Clark, S. J. (2012) · Breast Cancer Research · doi:10.1186/bcr3237 · Cited by 43
A New Role for ERα: Silencing via DNA Methylation of Basal, Stem Cell, and EMT Genes
Ariazi, E. A., Taylor, J., Black, M. A., Nicolas, É., Slifker, M. J., Azzam, D. J., & Boyd, J. A. (2017) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-16-0283 · Cited by 42
Epigenetic regulation of the intestinal epithelium
Elliott, E. N., & Kaestner, K. H. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1997-9 · Cited by 42
Predictive modelling of gene expression from transcriptional regulatory elements
Budden, D., Hurley, D., & Crampin, E. J. (2014) · Briefings in Bioinformatics · doi:10.1093/bib/bbu034 · Cited by 41
Choi, J.-H., Li, Y., Guo, J., Pei, L., Rauch, T. A., Kramer, R. S., Macmil, S. L., Wiley, G. B., Bennett, L. B., Schnabel, J. L., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013020 · Cited by 42
Hsiao, S., Chen, M.-W., Chen, C., Chien, M., Hua, K., Hsiao, M., Kuo, M., & Wei, L. (2015) · Annals of Surgical Oncology · doi:10.1245/s10434-015-4379-5 · Cited by 41
Wu, J., Zhao, S., Tang, Q., Zheng, F., Chen, Y., Yang, L., Yang, X., Li, L., Wu, W., & Hann, S. S. (2015) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-015-0215-9 · Cited by 41
Li, Q., Zhang, W., Li, J., Xiong, J., Liu, J., Chen, T., Wen, Q., Zeng, Y., Gao, L., Gao, L., et al. (2020) · Biomarker Research · doi:10.1186/s40364-020-00205-4 · Cited by 41
Wu, J.-E., Wu, Y.-Y., Tung, C.-H., Tsai, Y.-T., Chen, H., Chen, Y., & Hong, T.-M. (2020) · Theranostics · doi:10.7150/thno.45785 · Cited by 41
Genetic Background of Polycythemia Vera
Regimbeau, M., Mary, R., Hermetet, F., & Girodon, F. (2022) · Genes · doi:10.3390/genes13040637 · Cited by 42
Pereira, K. N. E., Shan, J., Licht, J. D., & Bennett, R. L. (2023) · Biochemical Society Transactions · doi:10.1042/bst20210567 · Cited by 41
Multiple binding of methyl‐CpG and polycomb proteins in long‐term gene silencing events
Matarazzo, M. R., Bonis, M. L. D., Strazzullo, M., Cerase, A., Ferraro, M., Vastarelli, P., Ballestar, E., Esteller, M., Kudo, S., & D’Esposito, M. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20879 · Cited by 41
Self-citationLillycrop, K. A., & Burdge, G. C. (2011) · Lifestyle Genomics · doi:10.1159/000334857 · Cited by 41
Chromatin and DNA methylation dynamics of Helicobacter pylori-induced COX-2 activation
Pero, R., Peluso, S., Angrisano, T., Tuccillo, C., Sacchetti, S., Keller, S., Tomaiuolo, R., Bruni, C. B., Lembo, F., & Chiariotti, L. (2010) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2010.06.009 · Cited by 41
Epigenetic regulation of adult stem cell function
Rinaldi, L., & Benitah, S. A. (2014) · FEBS Journal · doi:10.1111/febs.12946 · Cited by 42
Histone Methyltransferase and Histone Methylation in Inflammatory T-Cell Responses
He, S., Tong, Q., Bishop, D. K., & Zhang, Y. (2013) · Immunotherapy · doi:10.2217/imt.13.101 · Cited by 42
PPARGEpigenetic Deregulation and Its Role in Colorectal Tumorigenesis
Sabatino, L., Fucci, A., Pancione, M., & Colantuoni, V. (2012) · PPAR Research · doi:10.1155/2012/687492 · Cited by 41
Deciphering the cancer imprintome
Monk, D. (2010) · Briefings in Functional Genomics · doi:10.1093/bfgp/elq013 · Cited by 41
Puvvada, S. D., Li, H., Rimsza, L. M., Bernstein, S. H., Fisher, R. I., LeBlanc, M. L., Schmelz, M., Glinsmann‐Gibson, B., Miller, T. P., Maddox, A., et al. (2016) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2015.1135431 · Cited by 41
Shi, Z., Li, Y., Qian, X., Hu, Y., Liu, J., Zhang, S., & Zhang, J. (2017) · Journal of Cancer · doi:10.7150/jca.19315 · Cited by 41
miR-137: A Novel Therapeutic Target for Human Glioma
Wang, Y., Chen, R., Zhou, X., Guo, R., Yin, J., Li, Y., & Ma, G. (2020) · Molecular Therapy Nucleic Acids · doi:10.1016/j.omtn.2020.06.028 · Cited by 40
Polycomb group genes are targets of aberrant DNA methylation in renal cell carcinoma
Avissar-Whiting, M., Koestler, D. C., Houseman, E. A., Christensen, B. C., Kelsey, K. T., & Marsit, C. J. (2011) · Epigenetics · doi:10.4161/epi.6.6.16158 · Cited by 40
Genomic Approaches to Deconstruct Pluripotency
Loh, Y., Yang, L., Yang, J. C., Li, H., Collins, J. J., & Daley, G. Q. (2011) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-082410-101506 · Cited by 40
The Lasting Legacy of Social Stress on the Epigenome of the Hypothalamic–Pituitary–Adrenal Axis
Hoffmann, A., & Spengler, D. (2012) · Epigenomics · doi:10.2217/epi.12.34 · Cited by 37
Tang, J., Xie, Y., Xu, X., Yin, Y., Jiang, R., Deng, L., Tan, Z., Gangarapu, V., Tang, J., & Sun, B. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.81 · Cited by 40
Aberrant expression of ALK and EZH2 in Merkel cell carcinoma
Veija, T., Koljonen, V., Böhling, T., Kero, M., Knuutila, S., & Sarhadi, V. K. (2017) · BMC Cancer · doi:10.1186/s12885-017-3233-5 · Cited by 40
The Plasticizer Bisphenol A Perturbs the Hepatic Epigenome: A Systems Level Analysis of the miRNome
Renaud, L., da Silveira, W. A., Hazard, E. S., Simpson, J., Falcinelli, S., Chung, D., Carnevali, O., & Hardiman, G. (2017) · Genes · doi:10.3390/genes8100269 · Cited by 40
He, X., Wang, J., Chen, J., Han, L., Lu, X., Miao, D., Yin, D., Geng, Q., & Zhang, E. (2019) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.09.024 · Cited by 40
Zhang, Q., Kuang, G., He, S., Liu, S., Lu, H., Li, X., Zhou, D., & Huang, Y. (2020) · Nano Research · doi:10.1007/s12274-020-3066-4 · Cited by 40
PHF14 enhances DNA methylation of SMAD7 gene to promote TGF-β-driven lung adenocarcinoma metastasis
Tian, H., Liu, C., Yu, J., Han, J., Du, J., Liang, S., Wang, W., Liu, Q., Lian, R., Zhu, T., et al. (2023) · Cell Discovery · doi:10.1038/s41421-023-00528-0 · Cited by 40
Mechanisms of Epigenetic Regulation of Leukemia Onset and Progression
Ntziachristos, P., Mullenders, J., Trimarchi, T., & Aifantis, I. (2013) · Advances in immunology · doi:10.1016/b978-0-12-410524-9.00001-3 · Cited by 40
The Polycomb group protein Enhancer of Zeste 2: its links to DNA repair and breast cancer
Zeidler, M. G., & Kleer, C. G. (2006) · Journal of Molecular Histology · doi:10.1007/s10735-006-9042-9 · Cited by 40
Luca, A. D., Sacchetta, P., Nieddu, M., Ilio, C. D., & Favaloro, B. (2007) · BMC Molecular Biology · doi:10.1186/1471-2199-8-39 · Cited by 40
Menigatti, M., Cattaneo, E., Sabates–Bellver, J., Ilinsky, V. V., Went, P., Buffoli, F., Márquez, V. E., Jiricny, J., & Marra, G. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-124 · Cited by 40
Metadata
- Authors
- Viré, E., Brenner, C., Deplus, R., Blanchon, L., Fraga, M., Didelot, C., Morey, L., Van Eynde, A., Bernard, D., Vanderwinden, J.-M., Bollen, M., Esteller, M., Di Croce, L., de Launoit, Y., & Fuks, F.
- Affiliations
- Université Libre de Bruxelles (BE)
- Spanish National Cancer Research Centre (ES)
- KU Leuven (BE)
- Corresponding author
- Fuks, François
- ORCID
- Venue
- Nature
- Published
- 2005-12-14
- Volume
- 439
- Issue
- 7078
- Pages
- 871-874
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2053421436
- Cited by
- 2,204
- References
- 27
- Citations by year
- 2026: 32 · 2025: 52 · 2024: 60 · 2023: 72 · 2022: 89 · 2021: 110 · 2020: 95 · 2019: 94 · 2018: 95 · 2017: 119 · 2016: 151 · 2015: 134 · 2014: 128 · 2013: 135 · 2012: 164
- FWCI
- 33.51
- Type
- journal article
- Language
- en
- Update notices
- erratum (2007-04-12)
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
- HAL (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- Fédération Wallonie-Bruxelles
- Fondation pour la Recherche Médicale
- Ministerio de Economía y Competitividad
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Syndromes and Imprinting
- Keywords
- EZH2, Polycomb group proteins, DNA methylation, DNA methyltransferases, polycomb repressive complex 2, epigenetic silencing, chromatin repression, promoter methylation, protein-protein interaction
- MeSH terms
- Enhancer of Zeste Homolog 2 Protein, DNA (Cytosine-5-)-Methyltransferases, DNA-Binding Proteins, HeLa Cells, Humans, Promoter Regions, Genetic, Protein Binding, Repressor Proteins, Substrate Specificity, Transcription Factors, CpG Islands, DNA Methylation, Gene Silencing, Epigenesis, Genetic, Chromatin Immunoprecipitation, Polycomb-Group Proteins, Polycomb Repressive Complex 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.